We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Petitions FDA to Extend Market Exclusivity for Combo Drug Duavee
Pfizer Petitions FDA to Extend Market Exclusivity for Combo Drug Duavee
Pfizer is pressing the FDA to extend the market exclusivity of its combination drug Duavee, following a judge’s ruling that the FDA had inconsistently interpreted the eligibility criteria.